Atrium Therapeutics Inc. (RNA) Live Share Price, Invest From India

Atrium Therapeutics Inc. Stock Performance

as on June 19, 2026 at 2:16 pm IST

Day's Low
Day's High
$12.20
Day's Price Range
$12.95
$12.66
3.63%
Downside
2.29%
Upside
52 Week's Low
52 Week's High
$11.40
52-Week Price Range
$73.06
$12.66
9.93%
Downside
477.09%
Upside

Atrium Therapeutics Inc. share price movements today

Previous Close: $12.48
Open: $12.83
Volume: 233.5K
Day's Low - High: $12.20 - $12.95
52 Week Low - High: $11.40 - $73.06

Atrium Therapeutics Inc. Historical Returns

1 Month Return: -2.24 %
3 Month Return: -0.24 %
1 Year Return: -56.82 %
3 Year Return: + 4.46 %
5 Year Return: -52.78 %

Atrium Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Atrium Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$210.2M

EPS (TTM)

-5.25

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-59.0M

Revenue (TTM)

36.7M

Profit Margin

-159.99%

Return On Equity TTM

-43.98%

Atrium Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Atrium Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Atrium Therapeutics Inc.	BUY	$210.2M	-52.78%	NA	-159.99%	NA
Alnylam Pharmaceuticals Inc.	BUY	$37.7B	57.21%	71.21	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$116.5B	140.42%	27.22	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$63.7B	13.39%	14.85	29.65%	0.58%

Stock Returns calculator for Atrium Therapeutics Inc. Stock including INR - Dollar returns

The Atrium Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Atrium Therapeutics Inc. investment value today

Current value as on today

₹46,893

Returns

-₹53,107

(-53.11%)

Returns from Atrium Therapeutics Inc. Stock

-₹56,821 (-56.82%)

Dollar Impact

₹3,714 (+3.71%)

Analyst Recommendation on Atrium Therapeutics Inc. Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Atrium Therapeutics Inc.. Average target price of $25

Atrium Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Atrium Therapeutics Inc..

What analysts predicted

49.36%UPSIDE

Target Price

$25

Current Price

$12.66

Analyzed by

12 Analysts

Target

$25.00

Atrium Therapeutics Inc. target price $25, a slight upside of 49.36% compared to current price of $12.66. According to 12 analysts rating.

Indian Investors' Interest in Atrium Therapeutics Inc. Stock

Search interest for Atrium Therapeutics Inc. Stock has decreased by -43% in the last 30 days, reflecting a downward trend in search activity.

Time period: May 21, 2026 to June 20, 2026

Change:-43% versus previous 30 day period

Atrium Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	2	3	2	2	2	1	3	12	0	19
Gross Profit	1	2	1	2	2	1	-134	12	0	19
Operating Income	-66	-77	-82	-98	-120	-131	-171	-188	-48	-17
EBITDA	-66	-76	-81	-97	-120	-130	-170	-173	-47	-16
Interest Expense	0	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	1	0	0
Income Before Tax	-60	-68	-70	-80	-102	-115	-157	-174	-48	-16
Income Tax Expense	0	0	-	-	-	-	-	-	0	-
Net Income	-60	-68	-70	-80	-102	-115	-157	-174	-48	-16
Net Profit Margin	-2756.18%	-1943.41%	-3461.76%	-3441.70%	-3439.52%	-7360.01%	-4089.29%	-1398.33%	-5595.93%	-84.71%

Atrium Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	2	6	9	9	9	10	18
Gross Profit	-8	2	6	9	9	7	10	18
Operating Income	-10	-17	-44	-118	-178	-235	-378	-76
EBITDA	-10	-16	-43	-117	-177	-233	-376	-76
Interest Expense	0	7	0	0	5	-	-	-
Depreciation	0	0	0	0	1	1	2	0
Income Before Tax	-11	-24	-44	-118	-173	-212	-322	-76
Income Tax Expense	0	7	0	0	-4	1	-	0
Net Income	-11	-24	-43	-117	-169	-212	-322	-76
Net Profit Margin	-3148.81%	-1066.58%	-648.03%	-1258.52%	-1833.01%	-2219.87%	-2957.71%	-411.88%

Atrium Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-68	-70	-80	-102	-115	-157	-174	-29	-16
Operating Cash Flow	-70	-65	-65	-99	-124	-199	-156	-19	-31
Investing Cash Flow	-32	-274	-482	-64	157	185	-587	0	-2
Financing Cash Flow	389	446	342	13	1	3	850	20	301
Change in Cash	286	106	-205	-150	34	-10	106	32	267

Atrium Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2013	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-	-11	-24	-44	-118	-173	-212	-322	-49
Operating Cash Flow	-	-9	2	-37	-94	-136	-119	-300	-41
Investing Cash Flow	-	0	0	-7	-82	-189	-130	-854	-1
Financing Cash Flow	88	5	89	272	176	346	93	1,192	42
Change in Cash	-	-4	91	227	-1	19	-155	37	162

Global Institutional Holdings in Atrium Therapeutics Inc.

Funds	Holdings
UBS O'Connor LLC	2.4%
Fidelity International Ltd	0.74%
NORGES BANK	1.96%
Weiss Asset Management LP	1.39%
venBio Select Advisor LLC	3.52%

See all

Atrium Therapeutics Inc. News & Key Events

Insights on Atrium Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 3 Years
In the last 3 years, RNA has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -174.44M → -16.63M (in $), with an average increase of 226.0% per quarter
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 859.0K → 19.63M (in $), with an average increase of 95.6% per quarter
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 19.7% return, outperforming this stock by 76.5%
NEGATIVE IMPACT
Price Dip
In the last 6 months, RNA stock has moved down by -82.5%

About Atrium Therapeutics Inc.

Atrium Therapeutics, Inc., a biopharmaceutical company, focuses on delivering ribonucleic acid (RNA) therapeutics to the heart to transform the care for people living with cardiomyopathies. The company's development stage product candidates include ATR 1072, a siRNA-based therapy targeting PRKAG2 for the treatment of PRKAG2 syndrome; and ATR 1086, a siRNA-based therapy targeting PLN for the treatment of PLN cardiomyopathy. It also focuses on pipeline to treat a range of genetic and cardiac diseases. The company was incorporated in 2025 and is headquartered in San Diego, California.

Organisation	Atrium Therapeutics Inc.
Headquarters	10578 Science Center Drive, San Diego, CA, United States, 92121
Industry	Biotechnology
CEO	Ms. Kathleen P. Gallagher
E-voting on shares	Click here to vote

Key Management of Atrium Therapeutics Inc.

Name	Title
Ms. Stephanie Kenney	Chief Corporate Affairs Officer
Dr. Steven George Hughes M.B.A., M.D.	Chief Medical Officer
Ms. Rocio Martin Hoyos	Chief Strategy Officer
Ms. Kathleen P. Gallagher	President, CEO & Director
Mr. Brendan Winslow	Chief Financial Officer
Dr. Husam Younis	Chief Scientific Officer

FAQs

What is Atrium Therapeutics Inc. share price today?

Atrium Therapeutics Inc. share price today is $12.66 as on June 19, 2026 at 8:46 am IST at the close of the market. Atrium Therapeutics Inc. share today touched a day high of $12.95 and a low of $12.2.

What is the 52 week high and 52 week low for Atrium Therapeutics Inc. share?

Atrium Therapeutics Inc. share touched a 52 week high of $73.06 on February 3, 2026 and a 52 week low of $11.4 on June 11, 2026. Atrium Therapeutics Inc. stock price today i.e. June 19, 2026 at 8:46 am IST is closed at $12.66,which is 82.67% down from its 52 week high and 11.02% up from its 52 week low.

What is Atrium Therapeutics Inc.'s market capitalisation today?

Atrium Therapeutics Inc. market capitalisation is $0.00T as on June 19, 2026 at 8:46 am IST.

How to invest in Atrium Therapeutics Inc. Stock (RNA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Atrium Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Atrium Therapeutics Inc. Shares that will get you 0.1185 shares as per Atrium Therapeutics Inc. share price of $12.66 per share as on June 19, 2026 at 8:46 am IST.

What is the minimum amount required to buy Atrium Therapeutics Inc. Stock (RNA) from India?

Indian investors can start investing in Atrium Therapeutics Inc. (RNA) shares with as little as ₹94.31 or $1 (as of June 20, 2026 at 3:39 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in Atrium Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on June 20, 2026 at 3:39 pm IST). Based on Atrium Therapeutics Inc. share’s latest price of $12.66 as on June 19, 2026 at 8:46 am IST, you will get 0.7899 shares of Atrium Therapeutics Inc.. Learn more about fractional shares .

What are the returns that Atrium Therapeutics Inc. has given to Indian investors in the last 5 years?

Atrium Therapeutics Inc. stock has given -52.78% share price returns and 27.56% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?